Cost Comparison of Efanesoctocog Alfa with Existing Factor VIII Replacement Therapies for Major Surgeries in People with Severe Hemophilia A

Oral presentation is available to registered attendees only via the ASH annual meeting virtual platform, as per congress regulations. 

Session Name: 322. Hemophilia A and B: Clinical and Epidemiological: Poster II 

Session Date: Sunday, December 8, 2024 

Presentation Time: 6:00 PM - 8:00 PM 

Location: San Diego Convention Center, Halls G-H

Study funded by Sanofi.

Link to Published Abstract